Sfoglia per Rivista
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia
2004-01-01 ROSSI D; CAPELLO D; GLOGHINI A; FRANCESCHETTI S; PAULLI M; BHATIA K; SAGLIO G; VITOLO U; PILERI SA; ESTELLER M; CARBONE A; GAIDANO G.
ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS
2010-01-01 F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials
2013-01-01 Bringhen S;Mateos MV;Zweegman S;Larocca A;Falcone AP;Oriol A;Rossi D;Cavalli M;Wijermans P;Ria R;Offidani M;Lahuerta JJ;Liberati AM;Mina R;Callea V;Schaafsma M;Cerrato C;Marasca R;Franceschini L;Evangelista A;Teruel AI;van der Holt B;Montefusco V;Ciccone G;Boccadoro M;San Miguel J;Sonneveld P;Palumbo A
Aggressive subtypes of cutaneous T-cell lymphoma subsets: management and prognosis.
2003-01-01 BERNENGO M.G.; QUAGLINO P.
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients.
2006-01-01 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Fierro MT.
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML
2015-01-01 C. Panuzzo, G. Carrà, S. Crivellaro, R. Piazza, U. Familiari, S. Rocca, F. Fusella, G. Saglio, M. Brancaccio, A. Morotti
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy.
1999-01-01 Boccadoro M; Tarella C; Palumbo A; Argentino C; Triolo S; Dominietto A; Callea V; Lauta VM; Molica S; Musto P; Marmont F; Gianni AM; Pileri A
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy.
1999-01-01 BOCCADORO M ;TARELLA C ;PALUMBO A ;ARGENTINO C ;TRIOLO S ;DOMINIETTO A ;CALLEA V ;LAUTA VM ;MOLICA S ;MUSTO P ;MARMONT F ;GIANNI AM ;PILERI A
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins
1999-01-01 Tazzari PL; de Totero D; Bolognesi A; Testoni N; Pileri S; Roncella S; Reato G; Stein H; Gobbi M; Stirpe F
An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR
2007-01-01 MULLER MC; SAGLIO G; LIN F; PFEIFER H; PRESS RD; TUBBS RR; PASCHKA P; GOTTARDI; E; O'BRIEN SG; OTTMANN OG; STOCKINGER H; WIECZOREK L; MERX K; KNIG H; SCHWINDEL; U; HEHLMANN R; HOCHHAUS A
Analisi genomica del medulloblastoma in pazienti pediatrici
2007-01-01 Coco S; Pezzolo A; Capra V; Raso A; Nozza P; Longo L; Cama A; Gambini C; Pistoia V; Sandri A; Basso ME; Aschero S; Forni M; Madon E; Garrè ML; Cinalli G; Andolfo I; Zollo M; Iolascon A; Tonini GP
Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
2003-01-01 M. De Gobbi;F. Daraio;C. Oberkanins;A. Moritz;F. Kury;G. Fiorelli;C. Camaschella
Analysis of seven ribosomal protein genes in Italian Diamond Blackfan anemia patients
2010-01-01 Ramenghi U ;Quarello P ;Garelli E ;Carando A;Lorenzati A ;Ansaldi G;Davitto M ;Boria I; Aspesi A ;Dianzani I
Analysis of the breakpoint cluster region in essential thrombocythemia.
1990-01-01 Corradini P; Palumbo A; Battaglio S; Ponzio G; Boccadoro M; Pileri A
Analysis of the breakpoint cluster region in essential thrombocythemia.
1990-01-01 CORRADINI P ;PALUMBO AP ;BATTAGLIO S ;PONZIO G ;BOCCADORO M ;PILERI A
Analysis of the carbonyl compounds produced in beta thalassaemic erythrocytes by oxidative stress.
1989-01-01 RAMENGHI U; DAVID O; DIANZANI I; SACCHETTI L; BIASI F; CHIARPOTTO E; POLI G
Angiocentric lymphoma: a case report.
1990-01-01 DARBESIO A ;FERRERO D
Antitumor vaccination: where we stand.
2000-01-01 BOCCHIA M ;BRONTE V ;COLOMBO MP ;DE VINCENTIIS A ;DI NICOLA M ;FORNI G ;LANATA L ;LEMOLI RM ;MASSAIA M ;RONDELLI D ;ZANON P ;TURA S
ASSESSMENT OF THYMIC OUTPUT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES FOLLOWING NON-MYELOABLATIVE ALLOGRAFTING
2006-01-01 Bruno B; Sfiligoi C; Cena S; Gilestro M; Cimolin L; Sorasio R; Rotta M; Giaccone L; Galletto E; Omede P; Aiuti A; Boccadoro M
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy.
2013-01-01 Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia | 2004 | ROSSI D; CAPELLO D; GLOGHINI A; FRANCESCHETTI S; PAULLI M; BHATIA K; SAGLIO G; VITOLO U; PILERI SA; ESTELLER M; CARBONE A; GAIDANO G. | |
ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS | 2010 | F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo | |
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials | 2013 | Bringhen S;Mateos MV;Zweegman S;Larocca A;Falcone AP;Oriol A;Rossi D;Cavalli M;Wijermans P;Ria R;Offidani M;Lahuerta JJ;Liberati AM;Mina R;Callea V;Schaafsma M;Cerrato C;Marasca R;Franceschini L;Evangelista A;Teruel AI;van der Holt B;Montefusco V;Ciccone G;Boccadoro M;San Miguel J;Sonneveld P;Palumbo A | |
Aggressive subtypes of cutaneous T-cell lymphoma subsets: management and prognosis. | 2003 | BERNENGO M.G.; QUAGLINO P. | |
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. | 2006 | Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Fierro MT. | |
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML | 2015 | C. Panuzzo, G. Carrà, S. Crivellaro, R. Piazza, U. Familiari, S. Rocca, F. Fusella, G. Saglio, M. Brancaccio, A. Morotti | |
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. | 1999 | Boccadoro M; Tarella C; Palumbo A; Argentino C; Triolo S; Dominietto A; Callea V; Lauta VM; Molica S; Musto P; Marmont F; Gianni AM; Pileri A | |
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. | 1999 | BOCCADORO M ;TARELLA C ;PALUMBO A ;ARGENTINO C ;TRIOLO S ;DOMINIETTO A ;CALLEA V ;LAUTA VM ;MOLICA S ;MUSTO P ;MARMONT F ;GIANNI AM ;PILERI A | |
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins | 1999 | Tazzari PL; de Totero D; Bolognesi A; Testoni N; Pileri S; Roncella S; Reato G; Stein H; Gobbi M; Stirpe F | |
An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR | 2007 | MULLER MC; SAGLIO G; LIN F; PFEIFER H; PRESS RD; TUBBS RR; PASCHKA P; GOTTARDI; E; O'BRIEN SG; OTTMANN OG; STOCKINGER H; WIECZOREK L; MERX K; KNIG H; SCHWINDEL; U; HEHLMANN R; HOCHHAUS A | |
Analisi genomica del medulloblastoma in pazienti pediatrici | 2007 | Coco S; Pezzolo A; Capra V; Raso A; Nozza P; Longo L; Cama A; Gambini C; Pistoia V; Sandri A; Basso ME; Aschero S; Forni M; Madon E; Garrè ML; Cinalli G; Andolfo I; Zollo M; Iolascon A; Tonini GP | |
Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload. | 2003 | M. De Gobbi;F. Daraio;C. Oberkanins;A. Moritz;F. Kury;G. Fiorelli;C. Camaschella | |
Analysis of seven ribosomal protein genes in Italian Diamond Blackfan anemia patients | 2010 | Ramenghi U ;Quarello P ;Garelli E ;Carando A;Lorenzati A ;Ansaldi G;Davitto M ;Boria I; Aspesi A ;Dianzani I | |
Analysis of the breakpoint cluster region in essential thrombocythemia. | 1990 | Corradini P; Palumbo A; Battaglio S; Ponzio G; Boccadoro M; Pileri A | |
Analysis of the breakpoint cluster region in essential thrombocythemia. | 1990 | CORRADINI P ;PALUMBO AP ;BATTAGLIO S ;PONZIO G ;BOCCADORO M ;PILERI A | |
Analysis of the carbonyl compounds produced in beta thalassaemic erythrocytes by oxidative stress. | 1989 | RAMENGHI U; DAVID O; DIANZANI I; SACCHETTI L; BIASI F; CHIARPOTTO E; POLI G | |
Angiocentric lymphoma: a case report. | 1990 | DARBESIO A ;FERRERO D | |
Antitumor vaccination: where we stand. | 2000 | BOCCHIA M ;BRONTE V ;COLOMBO MP ;DE VINCENTIIS A ;DI NICOLA M ;FORNI G ;LANATA L ;LEMOLI RM ;MASSAIA M ;RONDELLI D ;ZANON P ;TURA S | |
ASSESSMENT OF THYMIC OUTPUT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES FOLLOWING NON-MYELOABLATIVE ALLOGRAFTING | 2006 | Bruno B; Sfiligoi C; Cena S; Gilestro M; Cimolin L; Sorasio R; Rotta M; Giaccone L; Galletto E; Omede P; Aiuti A; Boccadoro M | |
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy. | 2013 | Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile